GlassScriptPhysician profile
Hayden Merrill Pasco
NPI 1578724274
$4,059.79
in general payments reported to CMS, 2019-2025
33 companies · $996 in 2025
The $996 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $241 · 2021: $595 · 2022: $573 · 2023: $447 · 2024: $661 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,075 · Education: $28.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.37 |
| Education | $28.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $837.49 | 2021-2025 | |
| Novo Nordisk INC | $577.33 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amgen INC. | $550.29 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $299.01 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $274.84 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novartis Pharmaceuticals Corporation | $175.91 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $162.57 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.09 | 2023-2025 | |
| Pfizer INC. | $129.11 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $106.40 | 2019-2025 | Airsupra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $99.27 | 2020-2023 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $81.45 | 2020-2025 | Ajovy |
| Abbott Laboratories | $66.11 | 2022-2024 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $57.89 | 2022 | |
| Bausch Health US, LLC | $52.98 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $44.62 | 2019 | |
| Biogen, INC. | $36.33 | 2024-2025 | Leqembi |
| Amarin Pharma, INC. | $34.81 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $31.89 | 2021 | |
| Scpharmaceuticals INC. | $31.51 | 2024 | |
| Lundbeck LLC | $30.18 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $27.77 | 2019 | |
| Allergan, INC. | $26.67 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $26.66 | 2023 | Rexulti |
| Ardelyx, INC. | $18.81 | 2025 | Ibsrela |
| Esperion Therapeutics, INC. | $18.33 | 2022 | |
| Glaxosmithkline, LLC. | $18.07 | 2024 | Arexvy, Shingrix |
| Pacira Pharmaceuticals Incorporated | $17.86 | 2024 | Iovera, Zilretta, Exparel |
| Exact Sciences Corporation | $17.84 | 2025 | The Cologuard Plus Collection Kit |
| Impulse Dynamics (USA) INC. | $17.57 | 2023 | Optimizer |
| Shire North American Group INC | $15.23 | 2019 | |
| Assertio Therapeutics, INC. | $11.90 | 2020 | |
| Biodelivery Sciences International, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayden Pasco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.